Case File №
#VI-2026-0493
Tydes
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
40 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Mazdutide | C Okay | 3 | 5.0 | 4.7 | 5.4 | 25 Apr 2025 |
| Melanotan II | C Okay | 4 | 5.4 | 4.2 | 6.6 | 27 Feb 2025 |
| Tirzepatide | C Okay | 10 | 5.4 | 4.6 | 6.2 | 17 Dec 2024 |
| Retatrutide | D Poor | 9 | 5.2 | 3.8 | 7.2 | 17 Dec 2024 |
| Semaglutide | D Poor | 9 | 4.9 | 4.4 | 5.4 | 17 Dec 2024 |
| BPC-157 | E Bad | 5 | 4.0 | 2.7 | 4.9 | 17 Dec 2024 |
| Ipamorelin | X Unrated | 1 | 3.2 | 3.2 | 3.2 | 5 Mar 2025 |
| 1-Testosterone Cypionate (DHB) Raw | X N/A | 2 | 6.7 | 6.6 | 6.7 | 20 May 2026 |
| (2-Chloroethyl)benzene CAS 622-24-2 | X N/A | 1 | 4.0 | 2.6 | 2.6 | 6 May 2025 |
| 5-amino-1MQ | X N/A | 1 | 4.5 | 4.5 | 4.5 | 13 Feb 2025 |
| Anavar (Oxandrolone) | X N/A | 1 | 4.8 | 4.8 | 4.8 | 27 Feb 2025 |
| BAM15 | X N/A | 1 | 4.0 | 3.9 | 3.9 | 11 Jun 2025 |
| BPC157 10mg + TB500 10mg Blend | X N/A | 1 | 4.0 | 3.5 | 3.5 | 9 Jun 2025 |
| BPC157 5mg + TB500 5mg Blend | X N/A | 1 | 4.0 | 3.9 | 3.9 | 9 Jun 2025 |
| Cagrilintide 5mg + Semaglutide 5mg Blend | X N/A | 3 | 6.0 | 4.6 | 7.4 | 21 May 2026 |
| Cardiogen | X N/A | 2 | 7.0 | 6.6 | 7.5 | 24 May 2026 |
| Chonluten | X N/A | 1 | 9.0 | 9.0 | 9.0 | 20 Jun 2025 |
| CJC-1295 With DAC | X N/A | 4 | 5.2 | 2.7 | 6.9 | 23 May 2026 |
| CJC-1295 w/o DAC 5mg + IPA 5mg Blend | X N/A | 2 | 5.4 | 4.8 | 6.0 | 26 Jan 2026 |
| DSIP | X N/A | 3 | 4.7 | 3.3 | 6.7 | 23 May 2026 |
| EPO | X N/A | 2 | 4.5 | 3.3 | 5.8 | 26 Jan 2026 |
| FOXO4 | X N/A | 2 | 7.0 | 6.8 | 7.3 | 19 Jan 2026 |
| GLOW GHK-CU 35mg+TB500 10mg+BPC157 5mg | X N/A | 2 | 5.8 | 5.4 | 6.1 | 21 May 2026 |
| GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | X N/A | 3 | 4.3 | 3.1 | 5.9 | 25 May 2026 |
| KPV Oral | X N/A | 4 | 5.8 | 3.9 | 8.1 | 23 May 2026 |
| LGD-4033 (Ligandrol) | X N/A | 4 | 5.4 | 3.6 | 7.5 | 24 May 2026 |
| Masteron E (Drostanolone E) | X N/A | 4 | 4.7 | 3.7 | 5.8 | 24 May 2026 |
| Methylene Blue | X N/A | 3 | 5.4 | 3.8 | 7.2 | 25 May 2026 |
| MT-1 | X N/A | 2 | 6.2 | 6.2 | 6.3 | 20 May 2026 |
| Prednisone | X N/A | 4 | 5.7 | 4.9 | 7.1 | 21 May 2026 |
| Primobolan E | X N/A | 3 | 4.1 | 2.4 | 5.6 | 17 May 2026 |
| Retatrutide 30mg Pen Kit | X N/A | 4 | 5.2 | 3.6 | 6.6 | 19 Jan 2026 |
| Selank 10mg + Semax 10mg Blend | X N/A | 2 | 5.3 | 4.7 | 6.0 | 23 May 2026 |
| Supertest 450 | X N/A | 3 | 4.5 | 2.8 | 5.9 | 21 May 2026 |
| T3 (Liothyronine) | X N/A | 4 | 4.2 | 2.8 | 5.9 | 17 May 2026 |
| Tamoxifen (Nolvadex) Raw | X N/A | 4 | 5.0 | 4.2 | 5.5 | 26 Jan 2026 |
| Test Suspension | X N/A | 3 | 5.0 | 3.9 | 5.7 | 20 May 2026 |
| Tren Hex | X N/A | 2 | 5.2 | 5.1 | 5.2 | 19 Jan 2026 |
| TrenMix 200 | X N/A | 4 | 4.9 | 2.8 | 7.0 | 19 Jan 2026 |
| Winstrol Oil (Stanozolol) | X N/A | 2 | 4.2 | 2.7 | 5.6 | 23 May 2026 |
Exhibit II
Evidence Log
91 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | 1-Testosterone Cypionate (DHB) Raw | 4.0 C | 5g | 6.1g | +22.7% | 96.16% | 1yvv9q | Lab D | Community |
| 25 May 2026 | CJC-1295 With DAC | 4.2 C | 15mg | 16.5mg | +10.3% | 99.17% | 3hgata | Lab B | Community |
| 25 May 2026 | Winstrol Oil (Stanozolol) | 4.0 C | 250mg/ml | 228.0mg/ml | -8.8% | 97.68% | pcet9h | Lab E | Community |
| 24 May 2026 | Cagrilintide 5mg + Semaglutide 5mg Blend | 6.4 A | 2mg | 1.8mg | -11.0% | 97.51% | i7zo70 | Lab F | Community |
| 24 May 2026 | Cardiogen | 6.9 A | 20mg | 22.3mg | +11.7% | 96.50% | 372gc6 | Lab C | Public |
| 24 May 2026 | BAM15 | 4.0 C | 10mg | 12.1mg | +20.8% | 98.84% | ilavs0 | Lab D | Community |
| 24 May 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 6.2 A | 2mg | 2.2mg | +10.0% | 95.02% | mp58as | Lab B | Community |
| 24 May 2026 | Methylene Blue | 5.3 B | 100mg | 108.1mg | +8.1% | 95.44% | s9kodw | Lab G | Public |
| 24 May 2026 | Primobolan E | 4.0 C | 250mg/ml | 277.7mg/ml | +11.1% | 95.50% | gwaayp | Lab E | Public |
| 24 May 2026 | Anavar (Oxandrolone) | 5.8 B | 100mg | 92.8mg | -7.2% | 96.68% | osgy20 | Lab A | Public |
| 24 May 2026 | CJC-1295 With DAC | 5.9 B | 2mg | 2.5mg | +24.1% | 95.90% | 2a4qbm | Lab B | Community |
| 24 May 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 5.4 B | 2mg | 2.4mg | +19.8% | 95.68% | 9gw2v2 | Lab B | Community |
| 24 May 2026 | GLOW GHK-CU 35mg+TB500 10mg+BPC157 5mg | 4.0 C | 15mg | 15.9mg | +6.1% | 96.54% | gznvdx | Lab G | Public |
| 24 May 2026 | Supertest 450 | 5.4 B | 100mg/ml | 120.3mg/ml | +20.3% | 99.94% | gk58z1 | Lab E | Public |
| 23 May 2026 | BPC157 10mg + TB500 10mg Blend | 4.0 C | 30mg | 30.8mg | +2.8% | 95.33% | 44cmzg | Lab D | Community |
| 23 May 2026 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 4.7 C | 15mg | 17.2mg | +14.8% | 95.45% | 2wm4op | Lab A | Community |
| 23 May 2026 | KPV Oral | 5.0 B | 10mg | 11.9mg | +19.3% | 95.08% | vqgipd | Lab F | Public |
| 23 May 2026 | T3 (Liothyronine) | 4.9 C | 10mg | 10.9mg | +9.3% | 95.18% | i43mxb | Lab G | Community |
| 23 May 2026 | Tren Hex | 7.0 A | 100mg/ml | 119.2mg/ml | +19.2% | 95.24% | a737qd | Lab E | Public |
| 21 May 2026 | CJC-1295 With DAC | 8.0 A | 30mg | 33.7mg | +12.4% | 96.69% | nvesil | Lab E | Public |
| 21 May 2026 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 4.5 C | 5mg | 5.8mg | +16.6% | 99.88% | 47jkg4 | Lab A | Public |
| 21 May 2026 | Retatrutide 30mg Pen Kit | 4.4 C | 10mg | 10.6mg | +5.5% | 99.57% | svbbyj | Lab D | Community |
| 21 May 2026 | Tren Hex | 6.2 A | 200mg/ml | 222.4mg/ml | +11.2% | 95.82% | ejh6vc | Lab C | Public |
| 21 May 2026 | KPV Oral | 5.4 B | 50mg | 58.8mg | +17.6% | 99.63% | w3q3c8 | Lab C | Public |
| 21 May 2026 | KPV Oral | 6.8 A | 20mg | 19.5mg | -2.7% | 96.90% | s7qw1h | Lab G | Public |
| 21 May 2026 | Retatrutide 30mg Pen Kit | 5.6 B | 2mg | 1.7mg | -14.9% | 98.98% | 4o2vb0 | Lab F | Community |
| 21 May 2026 | Supertest 450 | 5.0 B | 100mg/ml | 115.1mg/ml | +15.1% | 96.17% | y0cmx3 | Lab G | Community |
| 21 May 2026 | T3 (Liothyronine) | 4.1 C | 20mg | 22.1mg | +10.4% | 95.18% | djntj4 | Lab C | Public |
| 20 May 2026 | EPO | 4.0 C | 30mg | 27.6mg | -8.0% | 96.05% | 635xrn | Lab B | Community |
| 20 May 2026 | Retatrutide 30mg Pen Kit | 4.1 C | 15mg | 18.1mg | +20.6% | 99.82% | xnv4om | Lab F | Public |
| 19 May 2026 | BPC157 5mg + TB500 5mg Blend | 4.0 C | 20mg | 18.0mg | -10.0% | 98.45% | wovltk | Lab G | Public |
| 19 May 2026 | Masteron E (Drostanolone E) | 4.0 C | 100mg/ml | 119.3mg/ml | +19.3% | 95.51% | hmf3kq | Lab C | Public |
| 17 May 2026 | FOXO4 | 6.4 A | 50mg | 58.5mg | +17.1% | 97.11% | u7yczy | Lab A | Public |
| 17 May 2026 | GLOW GHK-CU 35mg+TB500 10mg+BPC157 5mg | 6.1 A | 50mg | 58.7mg | +17.5% | 99.77% | bfj1wq | Lab C | Public |
| 17 May 2026 | Tamoxifen (Nolvadex) Raw | 4.8 C | 5g | 5.5g | +9.9% | 97.83% | mqiu1n | Lab A | Public |
| 29 Jan 2026 | Masteron E (Drostanolone E) | 4.9 C | 250mg/ml | 217.5mg/ml | -13.0% | 99.26% | usrfl0 | Lab D | Public |
| 29 Jan 2026 | Masteron E (Drostanolone E) | 6.0 A | 300mg/ml | 340.4mg/ml | +13.5% | 98.62% | cor4f6 | Lab B | Public |
| 29 Jan 2026 | T3 (Liothyronine) | 4.0 C | 10mg | 9.5mg | -4.6% | 99.04% | 18n0ph | Lab B | Public |
| 26 Jan 2026 | 5-amino-1MQ | 4.0 C | 20mg | 22.6mg | +12.8% | 97.35% | 9drke0 | Lab E | Community |
| 26 Jan 2026 | CJC-1295 With DAC | 4.0 C | 10mg | 11.0mg | +9.9% | 95.20% | 360w4k | Lab A | Public |
| 26 Jan 2026 | Prednisone | 6.9 A | 25mg | 24.5mg | -2.0% | 96.53% | gwg2k9 | Lab D | Community |
| 19 Jan 2026 | LGD-4033 (Ligandrol) | 5.0 B | 20mg | 19.4mg | -3.0% | 96.82% | mvu0cz | Lab G | Public |
| 19 Jan 2026 | Primobolan E | 4.0 C | 100mg/ml | 99.0mg/ml | -1.0% | 97.69% | kl3nel | Lab C | Public |
| 9 Jan 2026 | Cagrilintide 5mg + Semaglutide 5mg Blend | 4.0 C | 2mg | 2.4mg | +21.2% | 97.96% | zfbsjy | Lab B | Public |
| 9 Jan 2026 | TrenMix 200 | 6.3 A | 200mg/ml | 199.6mg/ml | -0.2% | 99.51% | y06wh1 | Lab B | Public |
| 7 Jan 2026 | Methylene Blue | 4.0 C | 20mg | 20.0mg | +0.0% | 96.78% | f9o28k | Lab C | Public |
| 7 Jan 2026 | Tamoxifen (Nolvadex) Raw | 6.3 A | 1g | 0.9g | -11.7% | 98.62% | f7r08h | Lab B | Community |
| 7 Jan 2026 | Test Suspension | 5.1 B | 300mg/ml | 306.8mg/ml | +2.3% | 96.69% | kajgbm | Lab G | Public |
| 7 Jan 2026 | TrenMix 200 | 7.0 A | 200mg/ml | 240.5mg/ml | +20.2% | 99.82% | elv1s2 | Lab G | Public |
| 6 Jan 2026 | T3 (Liothyronine) | 4.8 C | 100mg | 122.6mg | +22.6% | 97.53% | rnj70e | Lab D | Public |
| 6 Jan 2026 | Tamoxifen (Nolvadex) Raw | 4.0 C | 5g | 6.1g | +22.9% | 95.22% | do4bc2 | Lab F | Public |
| 29 Dec 2025 | Prednisone | 4.4 C | 10mg | 9.4mg | -5.9% | 98.79% | 9c3h5j | Lab A | Community |
| 29 Dec 2025 | Prednisone | 6.9 A | 25mg | 28.8mg | +15.1% | 98.23% | n474wf | Lab B | Public |
| 29 Dec 2025 | Primobolan E | 4.0 C | 200mg/ml | 244.8mg/ml | +22.4% | 97.70% | yvf99g | Lab B | Public |
| 29 Dec 2025 | Test Suspension | 6.1 A | 200mg/ml | 236.6mg/ml | +18.3% | 95.38% | j9g6dz | Lab C | Public |
| 12 Dec 2025 | DSIP | 5.5 B | 5mg | 5.1mg | +2.7% | 99.58% | gurw66 | Lab E | Public |
| 12 Dec 2025 | KPV Oral | 5.8 B | 10mg | 10.0mg | +0.5% | 95.46% | czbqh9 | Lab E | Public |
| 12 Dec 2025 | Selank 10mg + Semax 10mg Blend | 5.7 B | 20mg | 21.8mg | +9.2% | 95.47% | hn74fi | Lab B | Public |
| 12 Dec 2025 | Selank 10mg + Semax 10mg Blend | 5.5 B | 10mg | 9.6mg | -4.0% | 95.92% | 1moq3u | Lab E | Community |
| 12 Dec 2025 | TrenMix 200 | 4.0 C | 300mg/ml | 341.2mg/ml | +13.7% | 99.40% | 81kauf | Lab B | Public |
| 5 Dec 2025 | FOXO4 | 6.8 A | 30mg | 25.8mg | -14.0% | 95.59% | d4dpo2 | Lab D | Community |
| 5 Dec 2025 | Supertest 450 | 5.3 B | 300mg/ml | 361.9mg/ml | +20.6% | 96.67% | fkokog | Lab D | Community |
| 23 Nov 2025 | Cagrilintide 5mg + Semaglutide 5mg Blend | 7.1 A | 10mg | 8.5mg | -14.9% | 95.45% | 587406 | Lab G | Public |
| 23 Nov 2025 | Masteron E (Drostanolone E) | 4.1 C | 200mg/ml | 224.7mg/ml | +12.3% | 95.69% | 9jt8ar | Lab F | Public |
| 23 Nov 2025 | Prednisone | 4.0 C | 10mg | 10.0mg | -0.5% | 96.10% | 7u7wal | Lab B | Public |
| 17 Nov 2025 | 1-Testosterone Cypionate (DHB) Raw | 6.7 A | 500g | 580.1g | +16.0% | 98.87% | f0z3b7 | Lab F | Public |
| 17 Nov 2025 | DSIP | 4.9 C | 30mg | 35.2mg | +17.3% | 99.59% | vum7m3 | Lab D | Public |
| 17 Nov 2025 | MT-1 | 4.0 C | 5mg | 5.4mg | +7.6% | 98.79% | b46p3g | Lab C | Public |
| 14 Nov 2025 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 6.1 A | 50mg | 53.9mg | +7.8% | 98.95% | 320ryw | Lab E | Public |
| 5 Nov 2025 | DSIP | 4.2 C | 20mg | 24.8mg | +24.2% | 99.68% | m6q31h | Lab C | Public |
| 5 Nov 2025 | Tamoxifen (Nolvadex) Raw | 4.2 C | 5g | 4.7g | -5.9% | 95.78% | eh3iej | Lab G | Community |
| 5 Nov 2025 | Test Suspension | 5.8 B | 300mg/ml | 339.1mg/ml | +13.0% | 98.96% | odsgiy | Lab A | Public |
| 4 Nov 2025 | LGD-4033 (Ligandrol) | 6.0 A | 100mg | 113.3mg | +13.3% | 95.98% | vuqoxf | Lab A | Community |
| 4 Nov 2025 | LGD-4033 (Ligandrol) | 8.2 A | 100mg | 124.0mg | +24.0% | 96.14% | 8ayxrm | Lab F | Public |
| 4 Nov 2025 | MT-1 | 4.9 C | 30mg | 31.8mg | +6.0% | 95.15% | ihyf1x | Lab B | Community |
| 17 Oct 2025 | (2-Chloroethyl)benzene CAS 622-24-2 | 5.4 B | 500g | 565.4g | +13.1% | 95.85% | zi2jrc | Lab D | Community |
| 17 Oct 2025 | Chonluten | 10.0 A | 50mg | 54.8mg | +9.6% | 99.08% | 42vcb0 | Lab G | Community |
| 17 Oct 2025 | Retatrutide 30mg Pen Kit | 5.8 B | 10mg | 12.1mg | +21.0% | 99.26% | 1izxw4 | Lab C | Public |
| 9 Oct 2025 | Cardiogen | 5.7 B | 2mg | 2.1mg | +6.3% | 95.79% | m49l39 | Lab G | Public |
| 9 Oct 2025 | LGD-4033 (Ligandrol) | 5.9 B | 50mg | 60.3mg | +20.6% | 98.55% | asvtij | Lab G | Public |
| 3 Oct 2025 | EPO | 4.0 C | 20mg | 19.8mg | -0.8% | 99.32% | z4d9ga | Lab G | Public |
| 3 Oct 2025 | Methylene Blue | 6.3 A | 10mg | 10.9mg | +9.2% | 98.96% | p5l5r0 | Lab A | Community |
| 3 Oct 2025 | TrenMix 200 | 6.3 A | 250mg/ml | 255.8mg/ml | +2.3% | 97.99% | b2mm4k | Lab B | Public |
| 3 Oct 2025 | Winstrol Oil (Stanozolol) | 4.0 C | 200mg/ml | 174.5mg/ml | -12.8% | 99.20% | wxm0n3 | Lab F | Community |
| 30 Apr 2025 | Semaglutide | 5.4 C | 10mg | 11.69mg | +16.9% | 99.96% | (no batch ID) | Lab A | VendorInvestigator |
| 30 Apr 2025 | Mazdutide | 5.0 C | 6mg | 6.82mg | +13.7% | 99.58% | (no batch ID) | Lab A | VendorInvestigator |
| 30 Apr 2025 | Mazdutide | 4.7 D | 6mg | 6.9mg | +15.0% | 99.51% | (no batch ID) | Lab A | VendorInvestigator |
| 30 Apr 2025 | Retatrutide | 6.4 B | 10mg | 10.86mg | +8.6% | 99.72% | (no batch ID) | Lab A | VendorInvestigator |
| 30 Apr 2025 | Tirzepatide | 6.0 B | 10mg | 11.24mg | +12.4% | 99.97% | (no batch ID) | Lab A | VendorInvestigator |
| 30 Apr 2025 | Tirzepatide | 5.6 C | 10mg | 11.53mg | +15.3% | 99.94% | (no batch ID) | Lab A | VendorInvestigator |
| 30 Apr 2025 | Retatrutide | 7.2 A | 10mg | 10.61mg | +6.1% | 99.72% | (no batch ID) | Lab A | VendorInvestigator |
— END OF EVIDENCE LOG —